Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fidelity Advisor® Series Stock Selector Large Cap Value Fund (FMMLX)

Net Asset Value
1 Day
Overall Morningstar Rating
Large value
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund normally invests at least 80% of assets in stocks of companies with large market capitalizations (which- for purposes of this fund- are those companies with market capitalizations similar to companies in the Russell 1000- Index or the S&P 500- Index). It invests in securities of companies that Fidelity Management & Research Company (FMR) believes are undervalued in the marketplace in relation to factors such as assets- sales- earnings- growth potential- or cash flow- or in relation to securities of other companies in the same industry (stocks of these companies are often called "value" stocks).


1 month-0.73% 3 years+6.05%
3 months+3.52% 5 years--
1 year+11.20% Since inception+12.60%
Data through --

Peer Comparisonvs. Large value

Performance 5-yr return--+12.23%
Expense ratio0.00%1.04%
Risk 5 year sharpe ratio--1.21
Net assets$1.1B$2.8B
Average market cap$57.0B$91.1B
Average P/E18.419.0
Portfolio turnover48%48%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFidelity Investments
Fund manager & tenureKatherine Buck / 4 Years
Minimal initial investment$0.00
Minimum IRA investment--


U.S. stock91.26%
International stock2.81%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
BRKB Berkshire Hathaway3.77%
CVX Chevron3.52%
JNJ Johnson & Johnson2.69%
PG Procter & Gamble2.39%
WFC Wells Fargo2.23%
CSCO Cisco2.08%
COP ConocoPhillips1.91%
GS Goldman Sachs1.91%
T AT&T1.90%
PFE Pfizer1.73%